These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry. Zöllner SK; Kauertz KL; Kaiser I; Kerkhoff M; Schaefer C; Tassius M; Jabar S; Jürgens H; Ladenstein R; Kühne T; Haveman LM; Paulussen M; Ranft A; Dirksen U Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497417 [TBL] [Abstract][Full Text] [Related]
5. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine. Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382 [TBL] [Abstract][Full Text] [Related]
6. The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Palmerini E; Colangeli M; Nanni C; Fanti S; Marchesi E; Paioli A; Picci P; Cambioli S; Donati D; Cevolani L; De Paolis M; Gambarotti M; Ferrari S Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):215-223. PubMed ID: 27645694 [TBL] [Abstract][Full Text] [Related]
8. Results for patients with sarcoma not otherwise specified and other diagnoses than Ewing sarcoma treated according to the Euro-EWING 99 trial. Frank JA; Ranft A; Paulussen M; Juergens H; Kruseova J; Bauer S; Niggli F; Reichardt P; Dirksen U Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436593 [TBL] [Abstract][Full Text] [Related]
9. Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial. Heesen P; Ranft A; Bhadri V; Brichard B; Collaud S; Cyprova S; Eich H; Ek T; Gelderblom H; Hardes J; Haveman L; Jabar S; Hartmann W; Andreou D; Hauser P; Kersting J; Juergens H; Kanerva J; Kühne T; Raciborska A; Rascon J; Streitbürger A; Timmermann B; Uhlenbruch Y; Dirksen U Eur J Cancer; 2023 Oct; 192():113260. PubMed ID: 37595489 [TBL] [Abstract][Full Text] [Related]
10. Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94. Ash S; Yaniv I; Toledano H; Stein J; Kollender Y; Fenig E; Konen O; Bar-Sever Z; Issakov J; Avigad S; Cohen IJ J Pediatr Hematol Oncol; 2019 Mar; 41(2):105-111. PubMed ID: 30570510 [TBL] [Abstract][Full Text] [Related]
11. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma. Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879 [TBL] [Abstract][Full Text] [Related]
12. Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis. Martin E; Senders JT; Ter Wengel PV; Smith TR; Broekman MLD Acta Neurochir (Wien); 2019 Feb; 161(2):317-325. PubMed ID: 30578430 [TBL] [Abstract][Full Text] [Related]
13. Ewing sarcoma of the hand or foot. Froeb D; Ranft A; Boelling T; Paulussen M; Klco-Brosius S; Jürgens H; Dirksen U Klin Padiatr; 2012 Oct; 224(6):348-52. PubMed ID: 23143762 [TBL] [Abstract][Full Text] [Related]
14. Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma. Worch J; Ranft A; DuBois SG; Paulussen M; Juergens H; Dirksen U Pediatr Blood Cancer; 2018 Sep; 65(9):e27251. PubMed ID: 29856530 [TBL] [Abstract][Full Text] [Related]
15. Secondary Malignancies after Ewing Sarcoma-Epidemiological and Clinical Analysis of an International Trial Registry. Kaiser I; Kauertz K; Zöllner SK; Hartmann W; Langer T; Jürgens H; Ranft A; Dirksen U Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497401 [TBL] [Abstract][Full Text] [Related]
16. Real-world experiences in patients with Ewing sarcoma treated at a specialist centre in Turkey. Çakmakcı S; Sarı N; Atasever Akkaş E; Yıldız F; Karakaya E; Kaya B; Şafak Güngör B; Berna Çakmak Öksüzoğlu Ö; Ergürhan İlhan İ J Bone Oncol; 2024 Aug; 47():100619. PubMed ID: 39109280 [TBL] [Abstract][Full Text] [Related]
17. Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. Le Deley MC; Delattre O; Schaefer KL; Burchill SA; Koehler G; Hogendoorn PC; Lion T; Poremba C; Marandet J; Ballet S; Pierron G; Brownhill SC; Nesslböck M; Ranft A; Dirksen U; Oberlin O; Lewis IJ; Craft AW; Jürgens H; Kovar H J Clin Oncol; 2010 Apr; 28(12):1982-8. PubMed ID: 20308673 [TBL] [Abstract][Full Text] [Related]
18. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease. Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557 [TBL] [Abstract][Full Text] [Related]
19. Impact of the Interdisciplinary Tumor Board of the Cooperative Ewing Sarcoma Study Group on local therapy and overall survival of Ewing sarcoma patients after induction therapy. Kreyer J; Ranft A; Timmermann B; Juergens H; Jung S; Wiebe K; Boelling T; Schuck A; Vieth V; Streitbuerger A; Hardes J; Heinemann M; Dirksen U Pediatr Blood Cancer; 2018 Dec; 65(12):e27384. PubMed ID: 30084137 [TBL] [Abstract][Full Text] [Related]